Moderna Inc.
MRNA | NASDAQ
$172.94
+$18.90 (+12.27%)
At close: Sep 21, 2026, 4:00 PM ET
$170.84
-$2.10 (-1.21%)
Pre-market:
Sep 22, 2026, 5:42 AM ET
Market Data
Market Cap $61.12B
Enterprise Value $64.77B
Beta 0.90
Average Volume 13.26M
Shares Outstanding (Diluted) 396M
Shares Change YoY 2.06%
Institutional Ownership 78.00%
Exchange NASDAQ
ISIN US60770K1079
Price Performance
Price Change 1M 21.2%
Price Change 3M 183.5%
Price Change 6M 223.0%
Price Change YTD 460.4%
Price Change 1Y 551.1%
Price Change 3Y 73.0%
Price Change 5Y -59.8%
1M CAGR (ann.) 186.0%
1Y CAGR (ann.) 516.2%
5Y CAGR (ann.) -19.3%
All-Time CAGR 31.2%
Valuation
PE Ratio -21.67
Forward PE N/A
PEG Ratio 2.28
Forward PEG 0.45
PS Ratio 30.80
Forward PS 28.70
PB Ratio 10.15
P/FCF Ratio -56.11
P/Adj. FCF Ratio -43.65
P/OCF Ratio -65.02
EV/Sales 29.07
EV/EBIT -28.12
EV/EBITDA -22.03
EV/FCF -52.96
Earnings Yield -4.6%
FCF Yield -1.8%
Adj. FCF Yield -2.3%
Financial Health
Net Cash $4.5B
Total Debt $1.29B
Cash & Short-Term Investments $5.14B
Total Assets $10.96B
Current Ratio 2.29
Quick Ratio 2.18
Debt / Equity Ratio 0.19
Debt / EBITDA -0.44
Debt / FCF -1.05
OCF / Debt -0.82
Interest Coverage -132.80
Altman Z-Score 9.25
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin -12.6%
Operating Profit Margin -149.0%
EBITDA Margin -127.0%
Net Profit Margin -141.4%
FCF Margin -54.9%
Adj. FCF Margin -70.6%
SBC / Revenue 15.7%
SBC Impact (per share) -28.5%
Returns
Return on Assets -28.8%
Return on Equity -39.2%
Return on Invested Capital -39.2%
Return on Capital Employed -39.4%
Return on Tangible Assets -29.2%
Historical Growth (CAGR)
Revenue CAGR 3Y -40.5%
Revenue CAGR 5Y -19.7%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 36.0%
EPS CAGR 5Y -989.7%
EPS CAGR 10Y N/A
FCF CAGR 3Y 47.5%
FCF CAGR 5Y -4900.8%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 29
EPS Growth Next 3Y 35.4%
Revenue Growth Next 3Y 35.7%
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $115.70
Price Target Upside -33.1%
Cash Flow
Operating Cash Flow $-1.05B
Free Cash Flow $-1.22B
Adj. Free Cash Flow $-1.57B
FCF Per Share -$3.09
OCF Per Share -$2.66
OCF/S Ratio -47.2%
Income Statement
Revenue $2.23B
Gross Profit $-280M
Operating Income $-3.32B
EBITDA $-2.94B
Net Income $-3.15B
EPS (Diluted) -$7.98
Revenue / Employee $474.04K
Profit / Employee $-670.43K
Employees 4,700
Add to Watchlist
Select watchlists to add or remove MRNA